T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Chipotle Mexican Grill
CMG
$41.3B
| $978M | 0.2% |
75,176,250
-44,924,150
| -37% | -$613M |
|
|
RAD
127
DELISTED
Rite Aid Corporation
RAD
| $943M | 0.19% |
5,426,979
-80,939
| -1% | -$12.6M |
|
|
ALTR
128
DELISTED
Altera Corp
ALTR
| $942M | 0.19% |
21,944,433
-859,097
| -4% | -$30.7M |
|
129
Ross Stores
ROST
$79.5B
| $936M | 0.19% |
17,774,332
+1,582
| +0% | +$78.3K |
|
130
Applied Materials
AMAT
$438B
| $932M | 0.19% |
41,308,118
-5,221,148
| -11% | -$125M |
|
131
Illinois Tool Works
ITW
$83.2B
| $929M | 0.19% |
9,567,967
-763,165
| -7% | -$73.6M |
|
132
Bristol-Myers Squibb
BMY
$130B
| $929M | 0.19% |
14,403,704
-794,738
| -5% | -$49.8M |
|
133
Procter & Gamble
PG
$336B
| $925M | 0.19% |
11,287,930
-908,209
| -7% | -$78.1M |
|
134
T-Mobile US
TMUS
$190B
| $924M | 0.19% |
29,156,475
-1,720,462
| -6% | -$53.6M |
|
|
PLL
135
DELISTED
PALL CORP
PLL
| $921M | 0.19% |
9,178,540
-33,231
| -0.4% | -$3.36M |
|
|
HES
136
DELISTED
Hess
HES
| $920M | 0.19% |
13,561,255
-629,005
| -4% | -$44.9M |
|
137
Liberty Global Class C
LBTYK
$3.45B
| $919M | 0.19% |
22,803,132
-531,705
| -2% | -$21.1M |
|
138
Ametek
AME
$59.4B
| $918M | 0.19% |
17,464,199
+1,589,885
| +10% | +$81.4M |
|
139
Fidelity National Information Services
FIS
$21.6B
| $913M | 0.19% |
13,415,123
+48,705
| +0.4% | +$3.18M |
|
140
3M
MMM
$94.8B
| $907M | 0.19% |
6,575,478
-884,757
| -12% | -$122M |
|
141
Pentair
PNR
$10.6B
| $898M | 0.19% |
21,249,975
+7,487,683
| +54% | +$326M |
|
142
Norwegian Cruise Line
NCLH
$8.7B
| $891M | 0.18% |
16,495,404
+1,760,788
| +12% | +$84.1M |
|
143
Estee Lauder
EL
$31.9B
| $882M | 0.18% |
10,602,890
-815,109
| -7% | -$64.2M |
|
|
RDS.A
144
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $869M | 0.18% |
15,594,361
-4,972
| -0% | -$294K |
|
145
Ashland
ASH
$3.41B
| $864M | 0.18% |
13,866,762
+1,166,141
| +9% | +$70.6M |
|
146
Fidelity National Financial
FNF
$12.7B
| $855M | 0.18% |
33,506,495
-1,199,859
| -3% | -$30.2M |
|
147
Henry Schein
HSIC
$10.1B
| $852M | 0.18% |
15,557,933
-359,261
| -2% | -$19.7M |
|
148
Costco
COST
$421B
| $848M | 0.18% |
5,595,019
-809,615
| -13% | -$119M |
|
149
Cooper Companies
COO
$15B
| $841M | 0.17% |
17,953,228
+722,864
| +4% | +$30.5M |
|
150
Workday
WDAY
$42.9B
| $838M | 0.17% |
9,926,847
+3,267,450
| +49% | +$276M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.